G0 Cell Unit Researchers
(Left to right) Prof. Mitsuhiro Yanagida, technician Orie Arakawa, and Dr. Norihiko Nakazawa of the G0 Cell Unit authored a paper on the enzyme DNA topoisomerase II (topo II) a critical target for cancer therapy. Their experiments, conducted in yeast, revealed core mechanisms of topo II that could be exploited in future clinical studies.
Free for anyone to re-use, but must be credited to OIST.
This work is licensed under a Creative Commons Attribution 2.0 Generic License.